| Mar'18 | Dec'17 | Sep'17 | Jun'17 | Mar'17 | Dec'16 | Sep'16 | Jun'16 | Mar'16 |
|---|---|---|---|---|---|---|---|---|
Operating Activities | ||||||||
Net loss | ||||||||
-117,469 | -125,205 | 0 | 0 | 0 | - | - | - | - |
Net (loss) income | ||||||||
- | - | - | - | - | - | - | - | 0 |
Adjustments to reconcile net loss to net cash used in operating activities: | ||||||||
Depreciation and amortization | ||||||||
36,291 | 35,801 | 0 | 0 | 0 | - | - | - | - |
Depreciation and amortization | ||||||||
- | - | - | - | - | - | - | - | 0 |
Amortization of debt issuance costs | ||||||||
106 | 106 | 104 | 100 | 95 | 84 | 0 | 0 | 0 |
Change in fair value of contingent consideration | ||||||||
36,367 | 35,725 | 0 | 0 | 0 | - | - | - | - |
Payment of contingent consideration | ||||||||
0 | - | - | - | - | - | - | - | - |
Unrealized foreign currency transaction (gain) loss | ||||||||
-47 | 48 | 93 | 158 | -61 | 100 | 0 | 0 | 0 |
(Gain) loss on sale of fixed assets | ||||||||
-175 | 272 | 0 | 0 | 0 | - | - | - | - |
Change in fair value of warrants liability | ||||||||
- | -24 | -46 | -28 | -187 | -4,744 | 0 | 0 | 0 |
Share-based compensation expense | ||||||||
10,284 | 11,348 | 11,401 | 11,099 | 10,779 | 11,865 | 0 | 0 | 0 |
Benefit from deferred income taxes | ||||||||
0 | - | - | - | - | -3,952 | 0 | 0 | 0 |
Changes in operating assets and liabilities: | ||||||||
Accounts receivable | ||||||||
34,518 | -4,614 | 2,870 | 898 | -4,606 | 7,694 | 0 | 0 | 0 |
Inventory | ||||||||
1,447 | 1,811 | -45 | 159 | -166 | 819 | 0 | 0 | 0 |
Prepaid expenses and other current assets | ||||||||
-674 | 1,241 | -1,143 | -254 | -1,580 | -1,458 | 0 | 0 | 0 |
Accounts payable | ||||||||
-15,535 | 14,694 | 15,469 | 18,536 | 16,367 | -282 | 0 | 0 | 0 |
Accrued expenses and other liabilities | ||||||||
0 | - | - | - | 0 | - | - | - | - |
Deferred revenue | ||||||||
0 | - | - | - | - | - | - | - | - |
Other assets | ||||||||
0 | - | - | - | - | - | - | - | - |
Accrued expenses | ||||||||
- | - | - | - | - | - | 0 | 0 | 0 |
Other liabilities | ||||||||
- | - | - | - | - | - | 0 | 0 | 0 |
Net cash provided by operating activities | ||||||||
-20,697 | -28,786 | 0 | 0 | 0 | - | - | - | - |
Investing activities | ||||||||
Net cash (used in) provided by operating activities | ||||||||
- | - | - | - | - | - | - | - | 0 |
Acquisitions of businesses, net of cash acquired | ||||||||
- | - | - | - | - | 217,887 | 0 | 0 | 0 |
Purchases of property and equipment | ||||||||
393 | 1,822 | 3,854 | 5,210 | 5,228 | 4,166 | 0 | 0 | 0 |
Proceeds from sale of property and equipment | ||||||||
0 | - | - | - | - | - | - | - | - |
Other | ||||||||
- | 215 | 0 | 0 | 0 | - | - | - | - |
Net cash used in investing activities | ||||||||
132 | -1,514 | 0 | 0 | 0 | - | - | - | - |
Financing activities | ||||||||
Net cash used in investing activities | ||||||||
- | - | - | - | - | - | - | - | 0 |
Proceeds from issuance of convertible debt | ||||||||
- | - | - | - | - | 275,000 | 0 | 0 | 0 |
Proceeds from issuance of common stock | ||||||||
- | - | - | - | - | 75,000 | 0 | 0 | 0 |
Payment of debt and equity issuance costs | ||||||||
- | - | - | - | - | 778 | 0 | 0 | 0 |
Payment of contingent consideration | ||||||||
9,640 | 6,341 | 0 | 0 | 0 | - | - | - | - |
Proceeds from exercise of stock options / warrants | ||||||||
56 | 108 | 0 | 0 | 0 | - | - | - | - |
Proceeds (payments) related to settlement of stock awards | ||||||||
- | - | - | - | - | - | - | - | 0 |
Net cash used in financing activities | ||||||||
-9,584 | -6,233 | 0 | 0 | 0 | - | - | - | - |
Net cash (used in) provided by financing activities | ||||||||
- | - | - | - | - | - | - | - | 0 |
Net increase in cash and cash equivalents | ||||||||
-30,149 | -36,533 | -16,227 | -37,662 | -40,469 | 39,764 | 0 | 0 | 0 |
Effect of change in foreign exchange rates on cash and cash equivalents | ||||||||
307 | 482 | 425 | 406 | 172 | 363 | 0 | 0 | 0 |
Supplemental disclosure of cash flow information: | ||||||||
Income taxes paid | ||||||||
3,345 | 3,310 | 0 | 0 | 0 | - | - | - | - |
Interest paid | ||||||||
26,875 | 24,820 | 0 | 0 | 0 | - | - | - | - |